BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance
Go back to BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 64.87 +0.24 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.63 | 52 Week High | $108.96 | |||
| Open | $63.83 | 52 Week Low | $62.12 | |||
| Day High | $65.31 | P/E | N/A | |||
| Day Low | $63.64 | EPS | $-1.27 | |||
| Volume | 416,292 | |||||
